Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2018, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2018-08-10
DOI
10.1155/2018/7659243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development
- (2018) Natalia Nowak et al. KIDNEY INTERNATIONAL
- Associations of urinary, glomerular, and tubular markers with the development of diabetic kidney disease in type 2 diabetes patients
- (2017) Xu Jiang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Serum uromodulin is associated with impaired glucose metabolism
- (2017) Andreas Leiherer et al. MEDICINE
- Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
- (2017) Zubair Ilyas et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study
- (2017) Xian-Fei Zeng et al. BMC Nephrology
- Urinary Neutrophil Gelatinase-Associated Lipocalin Is Complementary to Albuminuria in Diagnosis of Early-Stage Diabetic Kidney Disease in Type 2 Diabetes
- (2017) Agnieszka Gala-Błądzińska et al. Biomed Research International
- Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients
- (2017) Khalid Al-Rubeaan et al. Scientific Reports
- Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes
- (2016) José Antonio M. de Carvalho et al. CLINICAL BIOCHEMISTRY
- Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes
- (2016) Agnieszka Żyłka et al. DISEASE MARKERS
- Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy
- (2016) Cristina Gluhovschi et al. Journal of Diabetes Research
- The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review
- (2016) Maria Narres et al. PLoS One
- Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
- (2015) Andrzej S. Krolewski DIABETES CARE
- A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes
- (2015) Michelle J. Pena et al. PLoS One
- Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
- (2014) Richard J. MacIsaac et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The serum uromodulin level is associated with kidney function
- (2014) Lorenz Risch et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients
- (2014) Sang Soo Kim et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
- (2014) Gudeta D. Fufaa et al. DIABETOLOGIA
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
- (2014) Ligia Petrica et al. PLoS One
- Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
- (2013) Valérie Pennemans et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus
- (2013) Nobumasa Ohara et al. JOURNAL OF HYPERTENSION
- Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus
- (2013) Mauro Boronat et al. RENAL FAILURE
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Notice
- (2012) Kidney International Supplements
- Diabetic kidney disease with and without albuminuria
- (2011) Richard J MacIsaac et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes
- (2011) F. L. Nauta et al. DIABETES CARE
- Treatment of Metabolic Syndrome Slows Progression of Diabetic Nephropathy
- (2011) Edgar G. Duran-Perez et al. Metabolic Syndrome and Related Disorders
- Uromodulin Biology and Pathophysiology – An Update
- (2010) Petr Vyletal et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Evidence for a role of uromodulin in chronic kidney disease progression
- (2010) S. Prajczer et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Kidney injury molecule-1 in renal disease
- (2009) Femke Waanders et al. JOURNAL OF PATHOLOGY
- Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients
- (2009) Davide Bolignano et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Lipocalin-2: Development, Analytical Characterization, and Clinical Testing of a New ELISA
- (2008) D. Stejskal et al. HORMONE AND METABOLIC RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started